An abbreviated version of the Brain Care Score predicts risk for dementia, stroke, and late-life depression based on lifestyle factors alone.

The FDA has granted Fast Track designation to ST-503 for the treatment of small fiber neuropathy, a chronic neuropathic pain disorder.

Artificial intelligence-enabled point-of-care EEG allows rapid bedside seizure detection, accelerating treatment and preventing unnecessary care escalation.

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

New recommendations focused on psychological intervention may help manage or reduce the impact of functional seizures.

Suzanna's Kitchen breaded chicken has been recalled after soy, a major allergen, was not identified on the packaging.

Among women with fibromyalgia, overactive bladder is prevalent and may often be associated with higher symptom severity and comorbidity.